![Regeneron Pharmaceuticals Inc.](https://cdn.asp.events/CLIENT_CloserSt_D86EA381_5056_B739_5482D50A1A831DDD/sites/opc-2023/media/libraries/exhibitors/4171eef1-f34f-11ee-bff-06bd0f937899-cover-image.png/fit-in/1500x9999/filters:no_upscale())
Founded by doctors and scientists over 30 years ago, Regeneron is a leading biotechnology company dedicated to inventing life-transforming medicines to help people with serious diseases.
Our science-driven approach includes research in eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases and rare diseases. In addition, our innovations include the VelociSuite® medicine discovery and development technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.
Date of Preparation: May 2024
GB.ONC.24.05.0001
Address
The Charter BuildingVine Street
Uxbridge
Middlesex
UB8 1JG
United Kingdom